Brief: Serina Therapeutics- On Sept 8, Board Appointed Steven Ledger To Be Chief Executive Officer
12/09/2024 23:10
Serina Therapeutics Inc SER.A :
* SERINA THERAPEUTICS- ON SEPT 8, BOARD APPOINTED STEVEN
LEDGER TO
BE CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:n0001493152-24-036080
Further company coverage: SER.A
Recent news on Serina Therapeutics
See all newsBrief: Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2
Brief: Serina Therapeutics - Offers Up To 12,500,000 Shares Of Common Stock By Roth Principal Investments - SEC Filing
Serina Therapeutics Q2 net loss widens on higher expenses
Brief: Serina Therapeutics Appoints Farrell Simon To Its Board Of Directors
Brief: Serina Therapeutics Completes Sentinel Dosing In Cohort 1 Of Phase 1B Registrational Trial Of SER-252